Christian Marth, MD, PhD

home / authors / christian-marth-md-phd

Articles

Is Neoadjuvant Chemotherapy in Ovarian Cancer an Excuse for Insufficient Surgery?

Christian Marth, MD, PhD;Alain Zeimet, MD, PhD;Andreas Du Bois, MD, PhD

September 13th 2011

Surgical debulking of epithelial ovarian carcinoma has been a mainstay of therapy for more than 50 years-since the approach was first advocated by Meigs in 1934.[1] In 1968, Munnell[2] introduced the idea of the "maximum surgical effort”-essentially the removal of as much cancer as possible.

Use of IP Chemotherapy in Ovarian Cancer: The Critical Questions

Edward L. Trimble, MD, PhD;Keiichi Fujiwara, MD, PhD;Christian Marth, MD, PhD;Jeffrey S. Abrams, MD

February 21st 2011

The article by Dr. Echarri Gonzalez and her colleagues regarding intraperitoneal (IP) chemotherapy for women with epithelial ovarian cancer provides a comprehensive yet practical review of the critical questions surrounding the use of IP chemotherapy.